Proving the Business Case for the Internet of Things

Mobile app provides boost for heart monitor

Steve Rogerson
March 16, 2015
 
The latest version of AliveCor’s AliveECG app has two FDA-cleared and CE-marked automated detectors that let patients and physicians focus on the ECGs that matter most. The mobile app instantly detects when an ECG is either normal or unreadable.
 
The normal detector lets patients to go about their regular daily activities knowing that no abnormalities were detected in their ECG. The interference detector goes a step beyond the existing filter to make sure the ECG is readable and physicians receive only the highest quality recordings.
 
Now anytime an ECG is taken with the heart monitor, the app will tell users if atrial fibrillation, a leading cause of stroke, is present; if the ECG is normal; or if there is too much interference and another ECG should be taken. These allow for the delivery of more efficient clinical decision making and follow-up, as physicians are able to focus on reviewing the ECGs that are most important.
 
"With the addition of these two new detectors, I now have an easy, clinically proven way to check my heart rhythm every day and see right away what's happening," said Paul Clarke, an AliveCor user since August 2014. "I feel extremely confident using my AliveCor heart monitor as I can go about my normal routine as well as after strenuous exercise without having to be worried that something is wrong with my heart. This feeling is priceless."
 
All three detectors are available on iOS and Android in the USA, UK, Ireland and India, and are free for a limited time.
 
"One of the most important things for our users is to provide them with confirmation that their ECG is normal, something typically only doctors could see," said Euan Thomson, president and chief executive officer at San Francisco-based AliveCor. “Our hard work on these automated detectors was validated when the FDA cleared this important diagnostic to be shared with consumers. When we introduced the atrial fibrillation detector we saw a 50 per cent increase in consumer recordings and expect similar results with our two new detectors."
 
The monitor can record, store and transfer single-channel ECG rhythms. It also displays ECG rhythms and detects the presence of atrial fibrillation and normal sinus rhythm, when prescribed or used under the care of a physician.
 
Intended for use by healthcare professionals, patients with known or suspected heart conditions and health conscious individuals, the device has not been tested for and it is not intended for pediatric use. It is compatible with all iOS and most Android OS mobile devices.
 
With secure storage in the cloud, users have the ability to access their data confidentially anytime, anywhere.